A128940 logo

Hanmi Pharm. Co., Ltd. Stock Price

KOSE:A128940 Community·₩6.1t Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A128940 Share Price Performance

₩483,000.00
187000.00 (63.18%)
₩483,000.00
187000.00 (63.18%)
Price ₩483,000.00

A128940 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with acceptable track record.

1 Risk
2 Rewards

Hanmi Pharm. Co., Ltd. Key Details

₩1.5t

Revenue

₩671.9b

Cost of Revenue

₩823.8b

Gross Profit

₩669.9b

Other Expenses

₩153.9b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
12.14k
55.08%
10.29%
0%
View Full Analysis

About A128940

Founded
1973
Employees
2400
CEO
Jae-Hyun Park
WebsiteView website
www.hanmipharm.com

Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company’s products include Gugutams, a urological combination therapy combining two active ingredients: tamsulosin, a treatment for Obstructive Prostatic Growth (OPG), and tadalafil, a treatment for erectile dysfunction (ED). The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.

Recent A128940 News & Updates

Hanmi Pharm. Co., Ltd.'s (KRX:128940) Shares Climb 29% But Its Business Is Yet to Catch Up

Nov 05
Hanmi Pharm. Co., Ltd.'s (KRX:128940) Shares Climb 29% But Its Business Is Yet to Catch Up

Recent updates

No updates

Hanmi Pharm. Co., Ltd. Competitors